Autologous intracoronary mononuclear bone marrow cell transplantation in chronic ischemic cardiomyopathy in humans

In this pilot trial intracoronary transplantation of autologous, mononuclear BMC did not lead to any significant improvement in myocardial function and physical performance of patients with chronic ischemic heart disease.